CDC RFA-PS-24-042: A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released from Prison
Submit ticket request // Limit: 1 // Tickets Available: 1
Only one application per institution (normally identified by having a unique entity identifier [UEI] number) is allowed.
This Notice of Funding Opportunity (NOFO) is designed to understand the feasibility and acceptability of providing long-acting injectable antiretroviral therapy (LAI-ART) to incarcerated persons with HIV who are soon to be released from state prison facilities. The ultimate goal is to support the development and implementation of effective, sustainable, replicable LAI-ART programs. People with HIV living in prison facilities are often released to the community lacking support for ongoing HIV care. There is a paucity of programs for this population demonstrating effectiveness with retention in care and maintaining sustained HIV viral suppression after release. The use of LAI-ART prior to and at the time of release from prison may improve adherence to HIV treatment, retention in care, and maintenance of viral load suppression among persons reentering the community. Applied qualitative and quantitative research resulting from this funding is expected to strengthen adherence to ART and is aligned with the HIV National Strategic Plan (2022-2025) and the Ending the HIV Epidemic in the U.S. (EHE) initiative “Treat” Pillar.